DD235637A5 - Verfahren zur herstellung von amidinverbindungen - Google Patents
Verfahren zur herstellung von amidinverbindungen Download PDFInfo
- Publication number
- DD235637A5 DD235637A5 DD85278877A DD27887785A DD235637A5 DD 235637 A5 DD235637 A5 DD 235637A5 DD 85278877 A DD85278877 A DD 85278877A DD 27887785 A DD27887785 A DD 27887785A DD 235637 A5 DD235637 A5 DD 235637A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- compounds
- compound
- acid
- complement
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15504584A JPS6133173A (ja) | 1984-07-25 | 1984-07-25 | アミジン化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD235637A5 true DD235637A5 (de) | 1986-05-14 |
Family
ID=15597463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD85278877A DD235637A5 (de) | 1984-07-25 | 1985-07-23 | Verfahren zur herstellung von amidinverbindungen |
Country Status (19)
Country | Link |
---|---|
US (2) | US4777182A (no) |
EP (1) | EP0190356B1 (no) |
JP (1) | JPS6133173A (no) |
KR (2) | KR870001087B1 (no) |
AU (1) | AU567039B2 (no) |
CA (1) | CA1254205A (no) |
CS (1) | CS255891B2 (no) |
DD (1) | DD235637A5 (no) |
DE (1) | DE3582057D1 (no) |
DK (1) | DK169069B1 (no) |
ES (1) | ES8607218A1 (no) |
FI (1) | FI78461C (no) |
HU (1) | HU195769B (no) |
MX (1) | MX160912A (no) |
NO (1) | NO163954C (no) |
PH (1) | PH20585A (no) |
SU (1) | SU1456008A3 (no) |
WO (1) | WO1986000893A1 (no) |
ZA (1) | ZA855552B (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3824236C1 (no) * | 1988-07-16 | 1989-12-28 | Heidelberger Druckmaschinen Ag, 6900 Heidelberg, De | |
CA2032420A1 (en) * | 1989-12-22 | 1991-06-23 | Akira Okuyama | Guanidinobenzene derivatives |
US5238964A (en) * | 1990-04-05 | 1993-08-24 | Torii & Co., Ltd. | Agent for treatment of cerebrovascular contraction |
US5652237A (en) * | 1994-09-09 | 1997-07-29 | Warner-Lambert Company | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes |
AU707215B2 (en) * | 1995-01-05 | 1999-07-08 | Torii Pharmaceutical Co., Ltd. | Thrombolytic agents |
WO1996020917A1 (fr) * | 1995-01-05 | 1996-07-11 | Torii Pharmaceutical Co., Ltd. | Derives d'ester d'amidinonaphtyle substitues |
KR100620935B1 (ko) | 1998-03-19 | 2006-09-13 | 브리스톨-마이어스스퀴브컴파니 | 용해도가 높은 약물에 대한 2상 서방성 전달 시스템과 방법 |
WO2001077082A1 (fr) * | 1999-06-02 | 2001-10-18 | Torii Pharmaceutical Co., Ltd. | Derives de naphtalene |
AU2000252458A1 (en) * | 2000-06-08 | 2001-12-17 | Shizuoka Coffein Co., Ltd. | Benzene derivatives |
EP2236136A1 (en) | 2005-05-17 | 2010-10-06 | Santen Pharmaceutical Co., Ltd. | Angiogenesis inhibitor containing amine derivate as active ingredient |
EP2143431A1 (en) | 2005-05-17 | 2010-01-13 | Santen Pharmaceutical Co., Ltd. | Protective agent for neurocyte comprising amidino derivative as active ingredient |
US20100063146A1 (en) * | 2006-11-07 | 2010-03-11 | Medof M Edward | Method for treating disorders related to complement activation |
JP6042330B2 (ja) | 2010-07-09 | 2016-12-14 | ビーエイチヴィ ファーマ、インコーポレイテッド | レモグリフロジンを含めた半減期が短い医薬品のための組合せ即時/遅延放出送達システム |
JP6252991B2 (ja) * | 2012-07-04 | 2017-12-27 | 味の素株式会社 | ナファモスタットメシル酸塩の製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292429A (en) * | 1978-03-08 | 1981-09-29 | Ciba-Geigy Corporation | Imidazole urea and amido compounds |
JPS57179146A (en) * | 1981-04-28 | 1982-11-04 | Torii Yakuhin Kk | Amidine compound |
AU527371B2 (en) * | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
JPS60130561A (ja) * | 1983-12-16 | 1985-07-12 | Torii Yakuhin Kk | アミジン誘導体およびそれを含む強心剤 |
-
1984
- 1984-07-25 JP JP15504584A patent/JPS6133173A/ja active Granted
-
1985
- 1985-07-12 WO PCT/JP1985/000392 patent/WO1986000893A1/ja active IP Right Grant
- 1985-07-12 CA CA000486773A patent/CA1254205A/en not_active Expired
- 1985-07-12 EP EP85903394A patent/EP0190356B1/en not_active Expired - Lifetime
- 1985-07-12 US US06/835,853 patent/US4777182A/en not_active Expired - Fee Related
- 1985-07-12 AU AU45492/85A patent/AU567039B2/en not_active Ceased
- 1985-07-12 DE DE8585903394T patent/DE3582057D1/de not_active Expired - Fee Related
- 1985-07-12 HU HU853727A patent/HU195769B/hu not_active IP Right Cessation
- 1985-07-12 KR KR1019860700140A patent/KR870001087B1/ko active
- 1985-07-23 ZA ZA855552A patent/ZA855552B/xx unknown
- 1985-07-23 ES ES545482A patent/ES8607218A1/es not_active Expired
- 1985-07-23 DD DD85278877A patent/DD235637A5/de not_active IP Right Cessation
- 1985-07-23 PH PH32559A patent/PH20585A/en unknown
- 1985-07-24 MX MX206081A patent/MX160912A/es unknown
- 1985-07-24 CS CS855463A patent/CS255891B2/cs not_active IP Right Cessation
-
1986
- 1986-03-03 DK DK096286A patent/DK169069B1/da not_active IP Right Cessation
- 1986-03-04 FI FI860904A patent/FI78461C/fi not_active IP Right Cessation
- 1986-03-07 NO NO86860865A patent/NO163954C/no not_active IP Right Cessation
- 1986-03-10 KR KR1019860700140A patent/KR860700250A/ko not_active IP Right Cessation
- 1986-03-24 SU SU864027333A patent/SU1456008A3/ru active
-
1988
- 1988-07-11 US US07/217,405 patent/US4820730A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR870001087B1 (ko) | 1987-06-04 |
WO1986000893A1 (en) | 1986-02-13 |
CS546385A2 (en) | 1987-07-16 |
JPS6133173A (ja) | 1986-02-17 |
JPH0461868B2 (no) | 1992-10-02 |
EP0190356B1 (en) | 1991-03-06 |
EP0190356A4 (en) | 1987-12-09 |
CA1254205A (en) | 1989-05-16 |
NO163954C (no) | 1990-08-15 |
EP0190356A1 (en) | 1986-08-13 |
DE3582057D1 (en) | 1991-04-11 |
US4777182A (en) | 1988-10-11 |
DK169069B1 (da) | 1994-08-08 |
FI78461C (fi) | 1989-08-10 |
CS255891B2 (en) | 1988-03-15 |
AU567039B2 (en) | 1987-11-05 |
DK96286A (da) | 1986-03-03 |
ZA855552B (en) | 1986-03-26 |
HUT42433A (en) | 1987-07-28 |
FI78461B (fi) | 1989-04-28 |
NO860865L (no) | 1986-04-10 |
ES545482A0 (es) | 1986-05-16 |
AU4549285A (en) | 1986-02-25 |
HU195769B (en) | 1988-07-28 |
SU1456008A3 (ru) | 1989-01-30 |
FI860904A (fi) | 1986-03-04 |
US4820730A (en) | 1989-04-11 |
ES8607218A1 (es) | 1986-05-16 |
NO163954B (no) | 1990-05-07 |
DK96286D0 (da) | 1986-03-03 |
FI860904A0 (fi) | 1986-03-04 |
KR860700250A (ko) | 1986-08-01 |
MX160912A (es) | 1990-06-14 |
PH20585A (en) | 1987-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3402628C2 (no) | ||
DE3207033C2 (de) | Amidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel | |
DE69628856T2 (de) | Substituierte n-[(aminoiminomethyl oder aminomethyl)phenyl]propylamide | |
DE60103390T2 (de) | Diazepinderivate oder deren salze | |
DD141520A5 (de) | Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden | |
DD201779A5 (de) | Verfahren zur herstellung neuer amidinverbindungen | |
DE2548886C2 (de) | p-(p'-Guanidinobenzoyloxy)-phenylcarbonsäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
DD235637A5 (de) | Verfahren zur herstellung von amidinverbindungen | |
DE10041402A1 (de) | Neue Verbindungen, die Faktor Xa-Aktivität inhibieren | |
DE3005580C2 (no) | ||
DE2065636A1 (de) | Neue tricyclische verbindungen | |
DE3031791C2 (no) | ||
DE2652201A1 (de) | Benzisothiazolone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
DE2316920C3 (de) | Benzo [d] [13] dioxolderivate, deren Herstellung und diese enthaltende Arzneimittel | |
DE10235639A1 (de) | Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel | |
EP0303951B1 (de) | 2-Pyrimidinyl-1-piperazin-Derivate zur Behandlung von Alkoholismus | |
EP1773855A1 (de) | Neue verbindungen, die faktor xa-aktivität inhibieren | |
DE60206376T2 (de) | Faktor xa inhibitor | |
DE2801478C2 (no) | ||
EP0665228A1 (de) | Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel | |
CH645368A5 (de) | 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate sowie verfahren zu deren herstellung. | |
DE3207023C2 (de) | Amidinverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten | |
DE3427865C2 (no) | ||
DE2939914C2 (de) | N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoylbenzamid-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel | |
DE2824066A1 (de) | Neue, zur ulcusbehandlung brauchbare verbindungen, verfahren zu deren herstellung, arzneimittel und zwischenprodukte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |